Rat Umbilical Cord Blood Cells Attenuate Hypoxic-ischemic Brain Injury in Neonatal Rats

Overview

Journal Sci Rep

Specialty Science

Date 2017 Mar 11

PMID 28281676

Citations 20

Authors

Keiko Nakanishi

Yoshiaki Sato

Yuka Mizutani

Miharu Ito

Akihiro Hirakawa

Yujiro Higashi

Affiliations

Soon will be listed here.

Abstract

Increasing evidence has suggested that human umbilical cord blood cells (hUCBC) have a favorable effect on hypoxic-ischemic (HI) brain injury. However, the efficacy of using hUCBCs to treat this injury has been variable and the underlying mechanism remains elusive. Here, we investigated its effectiveness using stereological analysis in an allogeneic system to examine whether intraperitoneal injection of cells derived from UCBCs of green fluorescent protein (GFP)-transgenic rats could ameliorate brain injury in neonatal rats. Three weeks after the HI event, the estimated residual brain volume was larger and motor function improved more in the cell-injected rats than in the control (PBS-treated) rats. The GFP-positive cells were hardly detectable in the brain (0.0057% of injected cells) 9 days after injection. Although 60% of GFP-positive cells in the brain were Iba1-positive, none of these were positive for NeuroD or DCX. While the number of proliferating cells increased in the hippocampus, that of activated microglia/macrophages decreased and a proportion of M2 microglia/macrophages increased in the ipsilateral hemisphere of cell-injected rats. These results suggest that intraperitoneal injection of cells derived from UCBCs could ameliorate HI injury, possibly through an endogenous response and not by supplying differentiated neurons derived from the injected stem cells.

Citing Articles

Systemic administration of clinical-grade multilineage-differentiating stress-enduring cells ameliorates hypoxic-ischemic brain injury in neonatal rats.

Ueda K, Sato Y, Shimizu S, Suzuki T, Onoda A, Miura R Sci Rep. 2023; 13(1):14958.

PMID: 37696826 PMC: 10495445. DOI: 10.1038/s41598-023-41026-3.

Progress in Research on Stem Cells in Neonatal Refractory Diseases.

Huang F, He Y, Zhang M, Luo K, Li J, Li J J Pers Med. 2023; 13(8).

PMID: 37623531 PMC: 10455340. DOI: 10.3390/jpm13081281.

Nonhematopoietic Umbilical Cord Blood Stem Cell Administration Improves Long-term Neurodevelopment After Periventricular-Intraventricular Hemorrhage in Neonatal Rats.

Rao R, Shiao M, Ennis-Czerniak K, Low W Cell Transplant. 2023; 32:9636897231189301.

PMID: 37493283 PMC: 10387682. DOI: 10.1177/09636897231189301.

The Long-Term Neuroprotective Effect of the Endocannabinoid 2-AG and Modulation of the SGZ's Neurogenic Response after Neonatal Hypoxia-Ischemia.

Beldarrain G, Hilario E, Lara-Celador I, Chillida M, Catalan A, Alvarez-Diaz A Pharmaceutics. 2023; 15(6).

PMID: 37376115 PMC: 10300731. DOI: 10.3390/pharmaceutics15061667.

Umbilical Cord Blood-Derived Cell Therapy for Perinatal Brain Injury: A Systematic Review & Meta-Analysis of Preclinical Studies.

Nguyen T, Purcell E, Smith M, Penny T, Paton M, Zhou L Int J Mol Sci. 2023; 24(5).

PMID: 36901781 PMC: 10001969. DOI: 10.3390/ijms24054351.

References

Migishima F, Oikawa A, Kondo S, Ema H, Morita Y, Nakauchi H . Full reconstitution of hematopoietic system by murine umbilical cord blood. Transplantation. 2003; 75(11):1820-6. DOI: 10.1097/01.TP.0000065295.99190.03. View

Ohshima M, Taguchi A, Tsuda H, Sato Y, Yamahara K, Harada-Shiba M . Intraperitoneal and intravenous deliveries are not comparable in terms of drug efficacy and cell distribution in neonatal mice with hypoxia-ischemia. Brain Dev. 2014; 37(4):376-86. DOI: 10.1016/j.braindev.2014.06.010. View

Fan C, Zhang Q, Tang F, Han Z, Wang G, Han Z . Human umbilical cord blood cells express neurotrophic factors. Neurosci Lett. 2005; 380(3):322-5. DOI: 10.1016/j.neulet.2005.01.070. View

Hattori T, Sato Y, Kondo T, Ichinohashi Y, Sugiyama Y, Yamamoto M . Administration of umbilical cord blood cells transiently decreased hypoxic-ischemic brain injury in neonatal rats. Dev Neurosci. 2015; 37(2):95-104. DOI: 10.1159/000368396. View

Nakanishi K, Aono S, Hirano K, Kuroda Y, Ida M, Tokita Y . Identification of neurite outgrowth-promoting domains of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan, and involvement of phosphatidylinositol 3-kinase and protein kinase C signaling pathways in neuritogenesis. J Biol Chem. 2006; 281(34):24970-8. DOI: 10.1074/jbc.M601498200. View

Gnecchi M, Zhang Z, Ni A, Dzau V . Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008; 103(11):1204-19. PMC: 2667788. DOI: 10.1161/CIRCRESAHA.108.176826. View

Xiong N, Cao X, Zhang Z, Huang J, Chen C, Zhang Z . Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats. Biol Blood Marrow Transplant. 2010; 16(11):1519-29. DOI: 10.1016/j.bbmt.2010.06.004. View

Emerson S, Sieff C, Wang E, Wong G, Clark S, Nathan D . Purification of fetal hematopoietic progenitors and demonstration of recombinant multipotential colony-stimulating activity. J Clin Invest. 1985; 76(3):1286-90. PMC: 424044. DOI: 10.1172/JCI112087. View

Uemura M, Kasahara Y, Nagatsuka K, Taguchi A . Cell-based therapy to promote angiogenesis in the brain following ischemic damage. Curr Vasc Pharmacol. 2012; 10(3):285-8. DOI: 10.2174/157016112799959369. View

10.

Sanberg P, Willing A, Garbuzova-Davis S, Saporta S, Liu G, Sanberg C . Umbilical cord blood-derived stem cells and brain repair. Ann N Y Acad Sci. 2005; 1049:67-83. DOI: 10.1196/annals.1334.008. View

11.

Zhao Y, Sun X, Cao W, Ma J, Sun L, Qian H . Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Acute Myocardial Ischemic Injury. Stem Cells Int. 2015; 2015:761643. PMC: 4461782. DOI: 10.1155/2015/761643. View

12.

Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe C, Siler D . Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke. 2009; 40(5):1849-57. DOI: 10.1161/STROKEAHA.108.534503. View

13.

Jung S, Schwartz M . Non-identical twins - microglia and monocyte-derived macrophages in acute injury and autoimmune inflammation. Front Immunol. 2012; 3:89. PMC: 3345364. DOI: 10.3389/fimmu.2012.00089. View

14.

Lindvall O, Kokaia Z . Stem cells for the treatment of neurological disorders. Nature. 2006; 441(7097):1094-6. DOI: 10.1038/nature04960. View

15.

de Paula S, Greggio S, Marinowic D, Machado D, DaCosta J . The dose-response effect of acute intravenous transplantation of human umbilical cord blood cells on brain damage and spatial memory deficits in neonatal hypoxia-ischemia. Neuroscience. 2012; 210:431-41. DOI: 10.1016/j.neuroscience.2012.03.009. View

16.

Borlongan C, Hadman M, Sanberg C, Sanberg P . Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke. 2004; 35(10):2385-9. DOI: 10.1161/01.STR.0000141680.49960.d7. View

17.

Jin K, Minami M, Lan J, Mao X, Batteur S, Simon R . Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci U S A. 2001; 98(8):4710-5. PMC: 31899. DOI: 10.1073/pnas.081011098. View

18.

Sato Y, Oohira A . Chondroitin sulfate, a major niche substance of neural stem cells, and cell transplantation therapy of neurodegeneration combined with niche modification. Curr Stem Cell Res Ther. 2009; 4(3):200-9. DOI: 10.2174/157488809789057419. View

19.

Chaudhary K, Haddadin S, Nistala R, Papageorgio C . Intraperitoneal drug therapy: an advantage. Curr Clin Pharmacol. 2010; 5(2):82-8. DOI: 10.2174/157488410791110779. View

20.

Rosenblum S, Wang N, Smith T, Pendharkar A, Chua J, Birk H . Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation. Stroke. 2012; 43(6):1624-31. DOI: 10.1161/STROKEAHA.111.637884. View